Percutaneous Coronary Intervention: Developments in the Last 12 Months

Percutaneous Coronary Intervention: Developments in the Last 12 Months

In 2018, there were several studies that significantly added to the field of interventional cardiology. Research was focused on understanding the role of percutaneous coronary intervention (PCI) in various clinical syndromes, optimizing outcomes for high-risk lesion subsets, and building an evidence...

Full description

Bibliographic Details
Main Authors: Rhian E Davies, J Dawn Abbott
Format: Article
Language:English
Published: Radcliffe Medical Media 2019-01-01
Series:US Cardiology Review
Online Access:https://www.uscjournal.com/articleindex/usc.2019.1.1
id doaj-0322a3c1729e4127a47d673e20631f86
record_format Article
spelling doaj-0322a3c1729e4127a47d673e20631f862021-10-09T16:01:02ZengRadcliffe Medical MediaUS Cardiology Review 1758-38961758-390X2019-01-01131111510.15420/usc.2019.1.1Percutaneous Coronary Intervention: Developments in the Last 12 MonthsRhian E Davies0J Dawn Abbott1Division of Cardiology, Rhode Island Hospital, Brown Medical School, Providence, RIDivision of Cardiology, Rhode Island Hospital, Brown Medical School, Providence, RIIn 2018, there were several studies that significantly added to the field of interventional cardiology. Research was focused on understanding the role of percutaneous coronary intervention (PCI) in various clinical syndromes, optimizing outcomes for high-risk lesion subsets, and building an evidence base for greater adoption of PCI guided by physiology and intracoronary imaging. In the area of innovation, novel and iterative developments in drug-eluting stents (DES) and scaffold platforms were compared with current generation DES. This article summarizes the research from last year which has had the most impact on PCI techniques and clinical care.https://www.uscjournal.com/articleindex/usc.2019.1.1
collection DOAJ
language English
format Article
sources DOAJ
author Rhian E Davies
J Dawn Abbott
spellingShingle Rhian E Davies
J Dawn Abbott
Percutaneous Coronary Intervention: Developments in the Last 12 Months
US Cardiology Review
author_facet Rhian E Davies
J Dawn Abbott
author_sort Rhian E Davies
title Percutaneous Coronary Intervention: Developments in the Last 12 Months
title_short Percutaneous Coronary Intervention: Developments in the Last 12 Months
title_full Percutaneous Coronary Intervention: Developments in the Last 12 Months
title_fullStr Percutaneous Coronary Intervention: Developments in the Last 12 Months
title_full_unstemmed Percutaneous Coronary Intervention: Developments in the Last 12 Months
title_sort percutaneous coronary intervention: developments in the last 12 months
publisher Radcliffe Medical Media
series US Cardiology Review
issn 1758-3896
1758-390X
publishDate 2019-01-01
description In 2018, there were several studies that significantly added to the field of interventional cardiology. Research was focused on understanding the role of percutaneous coronary intervention (PCI) in various clinical syndromes, optimizing outcomes for high-risk lesion subsets, and building an evidence base for greater adoption of PCI guided by physiology and intracoronary imaging. In the area of innovation, novel and iterative developments in drug-eluting stents (DES) and scaffold platforms were compared with current generation DES. This article summarizes the research from last year which has had the most impact on PCI techniques and clinical care.
url https://www.uscjournal.com/articleindex/usc.2019.1.1
work_keys_str_mv AT rhianedavies percutaneouscoronaryinterventiondevelopmentsinthelast12months
AT jdawnabbott percutaneouscoronaryinterventiondevelopmentsinthelast12months
_version_ 1716830419901480960

Similar Items